Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.
about
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)Multicenter Analytical Validation of Aβ40 Immunoassays.Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical DataMass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease.Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease.Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure.Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update.White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human BrainThe BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease
P2860
Q33771776-87D1E992-C098-4165-A613-A2DE624FE525Q33871427-BBAA15DC-E611-4408-B576-D2012E2BB9F0Q36354749-8BB48505-E89D-412B-84BD-C30FAE53B759Q46161119-88A1FBF1-633F-4DF7-A198-54D116050712Q47200597-C5519132-03FB-4396-BE5E-085DD53D0A24Q47428002-CF68EAE3-EB09-4FCD-B05B-311A32ED9B2AQ47587631-65045FC1-BA06-4997-933A-277C41768C9BQ47600734-373FADB9-81F5-4D9B-8FF9-71AC292851ACQ47761346-568C8829-E930-471C-B635-C16DF0E0047EQ47932570-4AC1F745-F755-478E-A290-93DB14244686Q53396427-94C9382E-6DAB-42F6-9661-8379A0040AF6Q58800826-171B0FA7-4B90-47A3-818B-9209BCC77BEBQ59133137-A70028F4-497A-44DD-B79C-260729BE2495
P2860
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Reference measurement procedur ...... ion study against amyloid PET.
@en
type
label
Reference measurement procedur ...... ion study against amyloid PET.
@en
prefLabel
Reference measurement procedur ...... ion study against amyloid PET.
@en
P2093
P2860
P50
P356
P1476
Reference measurement procedur ...... ion study against amyloid PET.
@en
P2093
Johan Gobom
Josef Pannee
Ulf Andreasson
P2860
P304
P356
10.1111/JNC.13838
P407
P577
2016-08-31T00:00:00Z